Drug & Supplement Interactions

Cannabis + Naratriptan

Brand name of Naratriptan

  • Amerge

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated October 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line No Known Interaction

We found no known interaction between Cannabis and Naratriptan in our sources.

This also applies to Amerge, a brand name of naratriptan.

Still Worth Knowing

  • Shared side effects: Although there is no interaction, both can cause some of the same side effects. Taken together, those side effects might add up, and a new symptom can be harder to pin on one or the other.
See the Full Interaction Report

Ask a Question About This Combination

Ask in your own words about taking Cannabis with Naratriptan. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Cannabis and Naratriptan Interaction Check

No Known Interaction Found

We did not find a documented interaction between Naratriptan and Cannabis in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

How We Checked

Why No Interaction Is Listed for Naratriptan

We sort drugs into categories, such as blood thinners or antibiotics, and many supplement interactions are recorded for a whole category rather than for one drug. So we checked every category Naratriptan is in against every category Cannabis has a known interaction with.

4Categories Naratriptan Is In
  • Qt Interval-Prolonging Drugs Drugs that can lengthen the QT interval, the part of each heartbeat when the heart recharges, such as some antibiotics, antidepressants and heart rhythm drugs. No Cannabis Record
  • Serotonergic Drugs Drugs that raise serotonin activity in the brain, such as many antidepressants (sertraline, fluoxetine), tramadol and triptans. No Cannabis Record
  • Serotonergic Drugs Drugs that raise serotonin activity in the brain, such as many antidepressants (sertraline, fluoxetine), tramadol and triptans. No Cannabis Record
  • Oral Drugs Any drug taken by mouth. No Cannabis Record
18Drug Categories Cannabis Interacts With
Show all 18 categories

No overlap. Naratriptan is in none of the 18 categories Cannabis interacts with, so no record links the two.

Still wondering about combining Cannabis and Naratriptan? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Know someone taking this combination? Share
What to Watch For

Side Effects Cannabis and Naratriptan Have in Common

8 side effects show up for both Cannabis and Naratriptan.

  • Each has separately been linked to the effects below. Taken together, they might add up: the same side effect from two sources might be more likely or stronger. No study of the two together says by how much.
  • If one turns up, it can be harder to tell which one is behind it, so tell your pharmacist you take both.
  • 3 of them are worth acting on rather than waiting out, marked below.
  • Serotonin syndrome Worth Acting On Additional detail

    Cannabis

    Smoking, vaping, or ingesting cannabis can cause headache, dizziness, numbness, disorientation, somnolence, and fatigue. Recurrent, strong headaches associated with cannabis use might be related to reversible cerebral vasoconstriction syndrome (RCVS). In one cohort, 32% of individuals with RCVS were cannabis users.

    Source: , the clinical database we license.

    6 references cited
    1. 17371. Ware MA, Wang T, Shapiro S, et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ 2010;182:e694-e701. PubMed
    2. 61896. Lynch, M. E. and Campbell, F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br.J.Clin.Pharmacol. 2011;72(5):735-744. PubMed
    3. 96384. Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: A systematic review and meta-analysis. JAMA. 2015;313(24):2456-73. PubMed
    4. 96813. Lotan I, Treves TA, Roditi Y, Djaldetti R. Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study. Clin Neuropharmacol. 2014;37(2):41-4. PubMed
    5. 101420. van de Donk T, Niesters M, Kowal MA, Olofsen E, Dahan A, van Velzen M. An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia. Pain. 2019 Apr;160(4):860-869. PubMed
    6. 113016. Chhabra M, Ben-Eltriki M, Paul A, Lê ML, Herbert A, Oberoi S, Bradford N, Bowers A, Rassekh SR, Kelly LE. Cannabinoids for symptom management in children with cancer: A systematic review and meta-analysis. Cancer. 2023 Nov 15;129(22):3656-3670. doi: 10.10 PubMed

    Naratriptan

    Source: Naratriptan’s

    It lists this side effect in its Adverse Reactions section.

    Read Naratriptan’s label on DailyMed ›
  • A heart attack Worth Acting On Additional detail

    Cannabis

    Cannabis use is associated with an increased risk of adverse cardiovascular events. A meta-analysis of observational studies in approximately 1.9 million adults suggests that cannabis use is associated with a 48% increased relative risk of a composite of adverse cardiovascular events compared with non-use.

    Cannabis has also been associated with acute coronary syndrome (ACS).

    Source: , the clinical database we license.

    6 references cited
    1. 118176. Sebastian SA, Shah Y, Arsene C, Krishnamoorthy G. Cannabis use and atherosclerotic cardiovascular disease outcomes: A meta-analysis of multinational cohort data. Dis Mon 2025;71(3):101849. PubMed
    2. 91920. Jouanjus E, Lapeyre-Mestre M, Micallef J; French Association of the Regional Abuse and Dependence Monitoring Centres (CEIP-A) Working Group on Cannabis Complications. Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart PubMed
    3. 96378. Goyal H, Awad HH, Ghali JK. Role of cannabis in cardiovascular disorders. J Thorac Dis. 2017;9(7):2079-2092. PubMed
    4. 104491. Lawin D, Lawrenz T, Tego A, Stellbrink C. Cannabis-induced recurrent myocardial infarction in a 21-year-old man: a case report. Eur Heart J Case Rep. 2020;4(3):1-5. PubMed
    5. 108688. Kasuda S, Kondo T, Terazawa I, Morimoto M, Yuui K, Kudo R. Cardiac sudden death in a young cannabis user. Leg Med (Tokyo) 2021;53:101955. PubMed
    6. 116443. Storck W, Elbaz M, Vindis C, et al. Cardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysis. Heart. 2025:heartjnl-2024-325429. PubMed

    Naratriptan

    Source: Naratriptan’s

    It lists this side effect in its Adverse Reactions section.

    Read Naratriptan’s label on DailyMed ›
  • An allergic reaction Worth Acting On Additional detail

    Cannabis

    Smoking or vaping cannabis can cause cough and bronchodilation. At least 5 cases of pneumomediastinum have been reported. These cases occurred in patients aged 19 to 27 years. In one case, cannabis was smoked the evening before symptoms occurred and in the others, cannabis was smoked daily or chronically; all cases made significant recoveries.

    Source: , the clinical database we license.

    6 references cited
    1. 17371. Ware MA, Wang T, Shapiro S, et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ 2010;182:e694-e701. PubMed
    2. 61799. Tetrault, J. M., Crothers, K., Moore, B. A., Mehra, R., Concato, J., and Fiellin, D. A. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch.Intern.Med. 2-12-2007;167(3):221-228. PubMed
    3. 96378. Goyal H, Awad HH, Ghali JK. Role of cannabis in cardiovascular disorders. J Thorac Dis. 2017;9(7):2079-2092. PubMed
    4. 96389. Ocampo TL, Rans TS. Cannabis sativa: the unconventional "weed" allergen. Ann Allergy Asthma Immunol. 2015;114(3):187-92. PubMed
    5. 99581. Ghasemiesfe M, Ravi D, Vali M, et al. Marijuana Use, Respiratory Symptoms, and Pulmonary Function: A Systematic Review and Meta-analysis. Ann Intern Med. 2018;169(2):106-115. PubMed
    6. 101420. van de Donk T, Niesters M, Kowal MA, Olofsen E, Dahan A, van Velzen M. An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia. Pain. 2019 Apr;160(4):860-869. PubMed

    Oral, topical, and occupational exposure to cannabis has been associated with reports of sensitization and allergic reactions. More than one allergen in cannabis may be responsible. Exposure to cannabis smoke can also cause nasal congestion, runny nose, sneezing, coughing, and wheezing, possibly related to an allergic response in some individuals.

    Cases of topical and airborne contact dermatitis have been reported af…

    Source: , the clinical database we license.

    6 references cited
    1. 96389. Ocampo TL, Rans TS. Cannabis sativa: the unconventional "weed" allergen. Ann Allergy Asthma Immunol. 2015;114(3):187-92. PubMed
    2. 116450. Wasik J, Likonska A, Kurowski M. IgE-Mediated Allergy and Asymptomatic Sensitization to Cannabis Allergens-Review of Current Knowledge and Presentation of Six Cases. Medicina (Kaunas) 2024;60(6):954. PubMed
    3. 112927. Fontane Hoyos CN, Boos J, Goldminz AM. Airborne allergic contact dermatitis to medical marijuana. Contact Dermatitis. 2024;90(1):89-91. PubMed
    4. 115374. Heyne S, Steininger J, Bauer A. Occupational allergic contact dermatitis to marijuana. Contact Dermatitis 2024. PubMed
    5. 111078. Li J, Miller M, Abu Khalaf S, Nelson TB. Weeding out the culprit: Cannabinoid-associated Stevens-Johnson Syndrome. Cureus 2023;15(5):e39454. PubMed
    6. 91918. Ozyurt S, Muderrisoglu F, Ermete M, Afsar F. Cannabis-induced erythema multiforme-like recurrent drug eruption. Int J Dermatol. 2014;53(1):e22-3. PubMed

    Naratriptan

    Source: Naratriptan’s

    It lists this side effect in its Adverse Reactions section.

    Read Naratriptan’s label on DailyMed ›
  • Drowsiness / Tiredness / Dizziness reported in 5.0% of FDA reports for Naratriptan Additional detail

    Cannabis

    Recorded for Cannabis in the same Natural Medicines adverse-effect record shown under A heart attack above.

    Naratriptan

    Source: Naratriptan’s

    It lists this side effect in its Adverse Reactions section. Voluntary reports to the FDA mention it too.

    Read Naratriptan’s label on DailyMed ›
  • Headache reported in 7.2% of FDA reports for Naratriptan Additional detail

    Cannabis

    Cannabis-based medicines, especially THC-dominant products, are associated with an increased risk of psychiatric adverse effects. A meta-analysis of available research shows that THC-dominant cannabis-based medicines increase psychiatric effects such as anxiety, confusion, dysphoria, and perceptual disturbances compared with control.

    When used short-term, smoking cannabis or using oromucosal spray containing cannabis…

    Source: , the clinical database we license.

    6 references cited
    1. 118162. Ates G, Welsch P, Klose P, et al. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2026;1(1):CD012182. PubMed
    2. 61896. Lynch, M. E. and Campbell, F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br.J.Clin.Pharmacol. 2011;72(5):735-744. PubMed
    3. 96814. Duran M, Pérez E, Abanades S, et al. Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. Br J Clin Pharmacol. 2010;70(5):656-63. PubMed
    4. 110242. Englund A, Oliver D, Chesney E, et al. Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios. Neuropsychopharmacology 2022. PubMed
    5. 110254. Hutten NRPW, Arkell TR, Vinckenbosch F, et al. Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis. Psychopharmacology (Berl) 2022;239(11):3731-374 PubMed
    6. 99583. Lawn W, Freeman TP, Pope RA, et al. Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses. Psychopharmacology (Berl). 2016;233(19-20):3537-52. PubMed

    Naratriptan

    Source: Naratriptan’s

    It lists this side effect in its Adverse Reactions section. Voluntary reports to the FDA mention it too.

    Read Naratriptan’s label on DailyMed ›
  • Nausea reported in 7.8% of FDA reports for Naratriptan Additional detail

    Cannabis

    Smoking and ingesting cannabis can cause xerostomia, nausea, and vomiting (13,18,2619,61896,96384,96813,113016,118172). Vaping cannabis has been reported to cause sore throat and bad taste in up to 35% of patients. Cannabis has also been reported to cause oral candidiasis. There have been 2 case reports of tongue candidiasis attributed to dry mouth after heavy cannabis use.

    Source: , the clinical database we license.

    6 references cited
    1. 13. Robbers JE, Speedie MK, Tyler VE. Pharmacognosy and Pharmacobiotechnology. Baltimore, MD: Williams & Wilkins, 1996.
    2. 18. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.
    3. 2619. Hebel SK, ed. Drug Facts and Comparisons. 52nd ed. St. Louis: Facts and Comparisons, 1998.
    4. 61896. Lynch, M. E. and Campbell, F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br.J.Clin.Pharmacol. 2011;72(5):735-744. PubMed
    5. 96384. Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: A systematic review and meta-analysis. JAMA. 2015;313(24):2456-73. PubMed
    6. 96813. Lotan I, Treves TA, Roditi Y, Djaldetti R. Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study. Clin Neuropharmacol. 2014;37(2):41-4. PubMed

    Naratriptan

    Source: Naratriptan’s

    It lists this side effect in its Adverse Reactions section. Voluntary reports to the FDA mention it too.

    Read Naratriptan’s label on DailyMed ›

Reported for Cannabis but not commonly for Naratriptan: a stroke or mini-stroke, a severe skin reaction, low blood pressure and an electrolyte imbalance.

Note: Effects for Naratriptan come from the Adverse Reactions section of its FDA label; effects for Cannabis come from the Natural Medicines adverse-effect record, quoted above. Where a percentage is shown, it is the share of 1,369 voluntary FDA FAERS reports for Naratriptan that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. The two sources word some effects differently, so we match them by meaning.

If You Decide to Take Both
  • Add one new thing at a time, and note the date you started it.
  • A start date turns “I’ve been feeling off” into something a pharmacist can work with.
  • Do not stop a prescribed medicine on your own.
  • Check with your pharmacist or doctor before changing any medicine or supplement, especially if you take several or have an ongoing health condition.

Beyond the Record

What Else We Found About Cannabis and Naratriptan

Pharmacist Q&AYou ask. We answer.

Questions Our Pharmacists Have Answered About Cannabis and Naratriptan

Real questions from readers, each answered by a licensed pharmacist at HelloPharmacist, written by a person and not generated from a database. An answer is written for the reader who asked and their situation, so read it for what to ask your own pharmacist rather than as a plan to follow.

Each one covers Cannabis or Naratriptan, not necessarily both.

  1. The pharmacist says

    Cannabis is not known to have a major documented interaction with binimetinib, though the combination hasn't been formally studied and your oncology team should approve use. Both cannabis and binimetinib can cause drowsiness, dizziness, and other overlapping side effects that may be stronger when used together, so you should monitor how you feel and avoid driving if impaired. Tell your cancer care team exactly what cannabis product you're using and how often so they can watch for any problems during your treatment.

    Answered by Dr. Brian Staiger, PharmD · July 2026
  2. The pharmacist says

    All triptans work similarly well overall, though individual response varies and some may work better for certain people than others. Rizatriptan shows the greatest response rate among oral triptans, while frovatriptan lasts the longest in your body. Triptans work best when taken at the first sign of a migraine and are available in multiple forms including oral tablets, nasal sprays, and injections.

    Answered by Dr. Brian Staiger, PharmD · November 2022
Published Research

Has Anyone Studied Cannabis With Naratriptan?

No published study names both Cannabis and Naratriptan. We searched . Most supplement and drug pairs have never been studied together.

Reports to the FDA

2 reports to the FDA list both Cannabis and Naratriptan.

What this means: someone took both, then had a health problem. It does not show either one caused it. In both newest reports, another medicine was the suspect. These two were 2 of the 10 to 28 products each person was taking.

  • 2Reports that list both
  • 1Marked serious by the reporter
  • 1From doctors, pharmacists and other health professionals
  • 1From patients and other consumers
The 2 Newest Reports
Who sent them, what happened and which medicine was suspected
ReceivedReported byWhat happenedMedicine suspectedCannabisNaratriptan
May 2025Report 25363431 A pharmacist Drug ineffective Vyepti10 products listed Also taking Also taking
November 2022Report 21595527 A consumer Trouble passing urine (urinary retention), Cholelithiasis, Blood clots (pulmonary embolism)Serious: hospital stay, medically important Ocrevus, Comirnaty (tozinameran) and 1 more28 products listed Also taking Also taking
Problems Named Most Often

Across all 2 reports, whatever was suspected. Not what this pair causes.

  • Tiredness (asthenia)1
  • Bacterial vaginosis1
  • Cholelithiasis1
  • Cough1
  • Covid-191
  • Drug ineffective1
How we searched

PubMed: searched October 2026, and again every few months. PubMed lists research but does not grade it; the finding above comes from our interaction records.

FDA reports: from the FDA Adverse Event Reporting System (FAERS) through openFDA, read October 2026. Matched by name, so a report may name a product that contains Cannabis. The counts are reports, not people, and no one checks them for cause. What FAERS is.

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Cannabis Does Interact With Other Medications

Cannabis has 2 major, 1,110 moderate, 25 minor known drug interactions in our database — Naratriptan isn’t one of them. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Cannabis

Covers the 2,830 medications we’ve checked against Cannabis. Pick one to open its full report.

Alternatives for the Same Use

Other Supplements for the Same Uses as Cannabis, and How They Mix With Naratriptan

Choosing a supplement while you take Naratriptan? Pick what you use Cannabis for to see other options studied for it, and whether each has a documented interaction with Naratriptan.

What do you take Cannabis for?

For Neuropathic Pain

None of them has a documented interaction with Naratriptan.

3 other supplements have at least some evidence of a benefit for neuropathic pain. Cannabis itself is graded for it.

For Multiple Sclerosis (MS)

1 of them has a documented interaction with Naratriptan: Panax Ginseng (moderate).

2 other supplements have at least some evidence of a benefit for multiple sclerosis (MS). Cannabis itself is graded for it.

The grades come from the Natural Medicines database and describe the research so far, not a recommendation, and none of these supplements replaces a prescribed medicine.

Everything Else You Take

See Every Supplement That Interacts With Naratriptan

Take other supplements too? 50 supplements have a documented interaction with Naratriptan, each explained on its page.

By severity: 8 major, 31 moderate and 11 minor.

The Most Serious There Right Now:

Open the Naratriptan interaction pageEvery supplement checked against Naratriptan, ranked by severity
One More Smart Check

Taking Cannabis as Part of a Dietary Supplement Product? Check It for Interactions

A product can hold more than Cannabis. We have broken down 21 supplement products that contain it, ingredient by ingredient. Find yours and we’ll check every ingredient against Naratriptan:

Get to Know Each One

About Cannabis and Naratriptan

Supplement

About Cannabis

Cannabis

Cannabis contains many active compounds, mainly THC (which causes a 'high') and CBD (which does not). Some uses, such as chemotherapy-related nausea, certain seizure disorders, and muscle spasticity, have meaningful evidence, while many other popular uses are not well proven. It can cause real side effects and impairment, so talk to your doctor or pharmacist and follow your local laws before using it.

Full Cannabis guide: uses, dosage, safety and every interaction

On Its Own

Cannabis Safety

Safety at a Glance

How Cannabis Is Rated

  • Cannabis Overall

    Use caution

    Can cause impairment, dependence, and mental health effects; use carefully and under medical guidance where legal.

  • Pregnancy

    Avoid

    Cannabis is not considered safe in pregnancy and may harm fetal development.

  • Breastfeeding

    Likely Unsafe

    When used orally or inhaled. Delta-9-tetrahydrocannabinol (THC) is concentrated and excreted in breast milk for longer than 6 weeks after cessation of cannabis use.

    Read the full breastfeeding detail ↓

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center), with the full detail in the next card.

Special Populations

Cannabis in Pregnancy & Breastfeeding

Lactation Likely Unsafe

When used orally or inhaled. Delta-9-tetrahydrocannabinol (THC) is concentrated and excreted in breast milk for longer than 6 weeks after cessation of cannabis use. Prolonged cannabis use during lactation has been associated with delayed motor development. Observational research in mothers who successfully abstained from cannabis use for 6 weeks (confirmed by a negative THC urine screen) after smoking cannabis prenatally at least twice weekly, found that THC levels in breastmilk increased during the first 2 weeks of abstinence and then decreased but remained detectable at 6 weeks. For patients planning to breastfeed, recommend abstaining from cannabis use prenatally and during lactation. Recommendations to discard breastmilk until THC levels are undetectable are not practical, as this may take more than 6 weeks. According to the American College of Obstetrics and Gynecology, cannabis use during lactation is discouraged due to limited long-term safety data in infants.

DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center

Medication

About Naratriptan

More to Explore

More Pairs and Interactions to Check

Keep Checking

Other Drugs & Cannabis

Browse every other medication we’ve checked against Cannabis — both the ones with a known interaction and the ones without. Select any drug for the full detail.

2Major
1,110Moderate
25Minor
1,692No known interaction
Major

Major: 2 interactions

Moderate

Moderate: 1,110 interactions

Showing 60 of 1,110 moderate interactions — see all 1,110 on the Cannabis page.

Minor

Minor: 25 interactions

No Interaction 1,692 drugs checked — show the list
How Much People Look This Up

Where Cannabis and Naratriptan Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Cannabis
Top 5%

#48 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Naratriptan
Top 25%

#699 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Cannabis and Naratriptan Together: Common Questions

Can you take Cannabis with Naratriptan?
We do not list a known interaction between Cannabis and Naratriptan. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Can you take Cannabis with Amerge?
Amerge is a brand name of naratriptan, so the answer is the same as for naratriptan. We do not list a known interaction between Cannabis and Naratriptan. Everything on this page applies to Amerge too.
Do Cannabis and Naratriptan have any of the same side effects?
Yes — our sources link each of them separately to 8 of the same effects. That is not a documented interaction, but taken together the same side effect from two sources might be more likely or stronger; no study of the two together says by how much. And if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
How was the Cannabis and Naratriptan combination checked?
Interactions in our licensed database are recorded against drug classes. Naratriptan is filed under 4 classifications, and Cannabis has documented interactions with 18 drug classes — none of Naratriptan's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Do other supplements studied for neuropathic pain interact with Naratriptan?
None of the 3 other supplements the Natural Medicines database grades as having some evidence of a benefit for neuropathic pain has a documented interaction with Naratriptan. A grade is the research so far, not a recommendation, and no known interaction is not proof of safety; ask your pharmacist before adding one.
Does Cannabis interact with any other medications?
Yes. Cannabis has 1,137 documented drug interactions in our database — Naratriptan is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Naratriptan interact with any supplements?
Yes. Naratriptan has documented interactions with 50 supplements in our database — Cannabis is not one of them. The Naratriptan interaction page linked on this page lists every one, ranked by severity.
Has Cannabis been studied with Naratriptan?
We searched PubMed, the National Library of Medicine's index of medical research, in October 2026, and found no study that names both Cannabis and Naratriptan. Most supplement and drug pairs have never been studied together, so no known interaction is not the same as proven safe.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Evidence & Sources

References Cited on This Page

The 28 references the cards above cite, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

Show the 28 references
  1. 13. Robbers JE, Speedie MK, Tyler VE. Pharmacognosy and Pharmacobiotechnology. Baltimore, MD: Williams & Wilkins, 1996.
  2. 18. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.
  3. 2619. Hebel SK, ed. Drug Facts and Comparisons. 52nd ed. St. Louis: Facts and Comparisons, 1998.
  4. 17371. Ware MA, Wang T, Shapiro S, et al. Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ 2010;182:e694-e701. PubMed
  5. 61799. Tetrault, J. M., Crothers, K., Moore, B. A., Mehra, R., Concato, J., and Fiellin, D. A. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch.Intern.Med. 2-12-2007;167(3):221-228. PubMed
  6. 61896. Lynch, M. E. and Campbell, F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br.J.Clin.Pharmacol. 2011;72(5):735-744. PubMed
  7. 91918. Ozyurt S, Muderrisoglu F, Ermete M, Afsar F. Cannabis-induced erythema multiforme-like recurrent drug eruption. Int J Dermatol. 2014;53(1):e22-3. PubMed
  8. 91920. Jouanjus E, Lapeyre-Mestre M, Micallef J; French Association of the Regional Abuse and Dependence Monitoring Centres (CEIP-A) Working Group on Cannabis Complications. Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart PubMed
  9. 96378. Goyal H, Awad HH, Ghali JK. Role of cannabis in cardiovascular disorders. J Thorac Dis. 2017;9(7):2079-2092. PubMed
  10. 96384. Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: A systematic review and meta-analysis. JAMA. 2015;313(24):2456-73. PubMed
  11. 96389. Ocampo TL, Rans TS. Cannabis sativa: the unconventional "weed" allergen. Ann Allergy Asthma Immunol. 2015;114(3):187-92. PubMed
  12. 96813. Lotan I, Treves TA, Roditi Y, Djaldetti R. Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study. Clin Neuropharmacol. 2014;37(2):41-4. PubMed
  13. 96814. Duran M, Pérez E, Abanades S, et al. Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. Br J Clin Pharmacol. 2010;70(5):656-63. PubMed
  14. 99581. Ghasemiesfe M, Ravi D, Vali M, et al. Marijuana Use, Respiratory Symptoms, and Pulmonary Function: A Systematic Review and Meta-analysis. Ann Intern Med. 2018;169(2):106-115. PubMed
  15. 99583. Lawn W, Freeman TP, Pope RA, et al. Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses. Psychopharmacology (Berl). 2016;233(19-20):3537-52. PubMed
  16. 101420. van de Donk T, Niesters M, Kowal MA, Olofsen E, Dahan A, van Velzen M. An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia. Pain. 2019 Apr;160(4):860-869. PubMed
  17. 104491. Lawin D, Lawrenz T, Tego A, Stellbrink C. Cannabis-induced recurrent myocardial infarction in a 21-year-old man: a case report. Eur Heart J Case Rep. 2020;4(3):1-5. PubMed
  18. 108688. Kasuda S, Kondo T, Terazawa I, Morimoto M, Yuui K, Kudo R. Cardiac sudden death in a young cannabis user. Leg Med (Tokyo) 2021;53:101955. PubMed
  19. 110242. Englund A, Oliver D, Chesney E, et al. Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios. Neuropsychopharmacology 2022. PubMed
  20. 110254. Hutten NRPW, Arkell TR, Vinckenbosch F, et al. Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis. Psychopharmacology (Berl) 2022;239(11):3731-374 PubMed
  21. 111078. Li J, Miller M, Abu Khalaf S, Nelson TB. Weeding out the culprit: Cannabinoid-associated Stevens-Johnson Syndrome. Cureus 2023;15(5):e39454. PubMed
  22. 112927. Fontane Hoyos CN, Boos J, Goldminz AM. Airborne allergic contact dermatitis to medical marijuana. Contact Dermatitis. 2024;90(1):89-91. PubMed
  23. 113016. Chhabra M, Ben-Eltriki M, Paul A, Lê ML, Herbert A, Oberoi S, Bradford N, Bowers A, Rassekh SR, Kelly LE. Cannabinoids for symptom management in children with cancer: A systematic review and meta-analysis. Cancer. 2023 Nov 15;129(22):3656-3670. doi: 10.10 PubMed
  24. 115374. Heyne S, Steininger J, Bauer A. Occupational allergic contact dermatitis to marijuana. Contact Dermatitis 2024. PubMed
  25. 116443. Storck W, Elbaz M, Vindis C, et al. Cardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysis. Heart. 2025:heartjnl-2024-325429. PubMed
  26. 116450. Wasik J, Likonska A, Kurowski M. IgE-Mediated Allergy and Asymptomatic Sensitization to Cannabis Allergens-Review of Current Knowledge and Presentation of Six Cases. Medicina (Kaunas) 2024;60(6):954. PubMed
  27. 118162. Ates G, Welsch P, Klose P, et al. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2026;1(1):CD012182. PubMed
  28. 118176. Sebastian SA, Shah Y, Arsene C, Krishnamoorthy G. Cannabis use and atherosclerotic cardiovascular disease outcomes: A meta-analysis of multinational cohort data. Dis Mon 2025;71(3):101849. PubMed

All 258 references behind our Cannabis records are listed in the Cannabis guide.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is reviewed by the HelloPharmacist Editorial Team. See our data sources and editorial standards.

Where Does Our Data Come From?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 105,612 references behind our interaction content, 67,053 of them resolved to verified PubMed/DOI sources. See the references behind this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified November 15, 2026. The Cannabis and Naratriptan records this page draws on were last updated October 13, 2026.
Data structure & sourcing designed and verified by .
Rating Key

What Our Interaction Ratings Mean

No interaction is on record for this pair. The other supplements and medicines on this page carry a severity rating: how serious an interaction between them is.

See what each severity means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Still Have a Question About Cannabis and Naratriptan?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.